| Patents for C12R 1 - Micro-organisms (92,025) |
|---|
| 04/19/2001 | WO2001027149A1 Human cervical cancer 1 protooncogene and protein encoded therein |
| 04/19/2001 | WO2001027143A1 Lantibiotic |
| 04/19/2001 | WO2001026680A2 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | WO2001026678A1 Short segments of dap-kinase |
| 04/19/2001 | WO2001026470A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/19/2001 | WO2001026458A2 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/19/2001 | WO2000060061A3 Transgenic plant resistant to mycotoxins and methods |
| 04/19/2001 | WO2000060060A3 Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| 04/19/2001 | WO2000050623A3 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives |
| 04/19/2001 | WO2000032047A9 Plasmid maintenance system for antigen delivery |
| 04/19/2001 | WO2000029444A9 Generation of antibodies using polynucleotide vaccination in avian species |
| 04/19/2001 | WO2000012720A9 Elongase genes and uses thereof |
| 04/19/2001 | DE10030529A1 New ester-cleaving enzyme from Thermomonospora fusca, useful for degrading e.g. polyesters, for recycling or surface modification |
| 04/19/2001 | CA2388232A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | CA2387541A1 Short segments of dap-kinase |
| 04/19/2001 | CA2387484A1 Adeno-associated virus vectors encoding factor viii and methods of using the same |
| 04/19/2001 | CA2387063A1 Activation of antigen-specific t cells by virus/antigen-treated dendritic cells |
| 04/19/2001 | CA2386181A1 Converting diploidy to haploidy for genetic diagnosis |
| 04/19/2001 | CA2384805A1 Recombinant, replication defective celo virus and celo virus dna |
| 04/19/2001 | CA2383965A1 Biosynthesis of polyketide synthase substrates |
| 04/19/2001 | CA2382737A1 Suppressor cells for prevention and treatment of immune responses in transplantation |
| 04/19/2001 | CA2382658A1 Process for increasing crop yield or biomass using protoporphyrinogen oxidase gene |
| 04/18/2001 | EP1092780A1 Recombiant, replication defective CELO virus and CELO virus DNA |
| 04/18/2001 | EP1092776A1 Method for producing L-amino acid by fermentation |
| 04/18/2001 | EP1092775A1 Methods for identifiying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 04/18/2001 | EP1092770A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same |
| 04/18/2001 | EP1092439A1 Activation of antigen-specific T cells by virus/antigen-treated dendritic cells |
| 04/18/2001 | EP1092040A2 METHODS OF INHIBITING $i(HELICOBACTER PYLORI) |
| 04/18/2001 | EP0914149A4 Purification and characterization of alkaline phosphatase from thermotoga neapolitana |
| 04/18/2001 | EP0766566B1 A conjugate between a modified superantigen and a target-seeking compound and the use of the conjugate |
| 04/18/2001 | EP0688431B1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 04/18/2001 | EP0604635B1 Macrophage cell line for an antinuclear antibody test; a method for detecting the said antibody by employing the macrophage cell line and a slide preparation |
| 04/18/2001 | CN1292031A Methods for producing polypeptide in bacillus cell |
| 04/18/2001 | CN1292030A Modified forms of pullulanase |
| 04/18/2001 | CN1292029A Compounds for therapy and diagnosis for lung cancer and method for their use |
| 04/18/2001 | CN1292028A Maltogenic alpha-amylase variants |
| 04/18/2001 | CN1291651A New nucleotide sequence of encode thrE gene and method of producing L-threonine using corynebacterium enzyme |
| 04/17/2001 | US6218528 MurB |
| 04/17/2001 | US6218513 Genetically engineered hemoglobins; for used to treat anemia and hemorrhages; for amplification of cells oxygen carrying capabilities |
| 04/17/2001 | US6218510 Proteins associated with the activation of lymphocytes and monocytes; for treatment of immune defects |
| 04/17/2001 | US6218398 Nocathiacin antibiotics |
| 04/17/2001 | US6218372 Methods for treating restenosis with p21 |
| 04/17/2001 | US6218188 Polynucleotide sequence for expression of pesticide in eukaryotic cells; for biological pest control |
| 04/17/2001 | US6218187 Infect human stem cells with microoganism supernatant; transfect cells, separate cells from supernatant, add adhesion molecules to culture plates, propagate second group of cells with supernantant and recover transduced cells |
| 04/17/2001 | US6218168 Process for preparing O-acetylserine, L-cysteine and L-cysteine-related products |
| 04/17/2001 | US6218164 Thermopallium bacteria and enzymes obtainable therefrom |
| 04/17/2001 | US6218158 Producing methyl ketones from fat by uniformly distributing fat, water, and enzyme-producing microorganism throughout porous bed, passing oxygen through bed without fluidizing or stirring, recovering oxidized product |
| 04/17/2001 | US6218157 Haloacetoacetate reductase, method for producing said enzyme, and method for producing alcohols using said enzyme |
| 04/17/2001 | US6218156 Gene encoding carbonyl reductase, and methods for its use |
| 04/17/2001 | US6218149 Altering affinity of antibody for antigen by deleting dna encoding a carbohydrate recognition site from variable domain of antibody, expressing mutagenized gene, measuring affinity of altered antibody and comparing to control |
| 04/17/2001 | US6218148 DNS encoding stem cell factor |
| 04/17/2001 | US6218123 Construction of normalized cDNA libraries from eucaryotic cells |
| 04/17/2001 | US6218107 Compositions and methods for detecting the presence of Mycobacterium kansassii |
| 04/17/2001 | US6218104 Method of detection of carcinogenic human papillomavirus |
| 04/17/2001 | US6217866 Antitumor agents mixture |
| 04/17/2001 | US6217859 Orally administering genetic engineered bacteria |
| 04/17/2001 | CA2210506C Thermostable dna polymerase from bacillus pallidus |
| 04/17/2001 | CA2205892C Mutant prenyl diphosphate synthase |
| 04/17/2001 | CA2125985C Stem cell inhibiting proteins |
| 04/17/2001 | CA2074824C Process for depleting viruses in solutions and for determining the depletion rate of the viruses |
| 04/12/2001 | WO2001025792A1 Assaying in vivo t-cell response upon dna vaccination |
| 04/12/2001 | WO2001025469A2 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | WO2001025467A1 Improved fermentation process |
| 04/12/2001 | WO2001025462A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | WO2001025445A1 Fibrinolytically active polypeptide |
| 04/12/2001 | WO2001025433A2 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | WO2001025426A1 Gene encoding protein capable of regenerating luciferin, novel recombinant dna and process for producing protein capable of regenerating luciferin |
| 04/12/2001 | WO2001025414A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | WO2001025246A2 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same |
| 04/12/2001 | WO2000049166A3 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 04/12/2001 | WO2000031241A3 Polypeptides having choline oxidase activity and nucleic acids encoding same |
| 04/12/2001 | WO2000026667A9 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 04/12/2001 | WO1998016632B1 MATERIALS AND METHODS FOR DETECTION OF $i(OXALOBACTER) |
| 04/12/2001 | WO1997004099A3 Papillomaviruses, agents for detecting them and for treating diseases caused by such viruses |
| 04/12/2001 | DE19947792A1 Neue für das Irp Gen codierende Nukleotidsequenzen New gene nucleotide sequences coding for the Irp |
| 04/12/2001 | DE19947791A1 Neue für das eno-Gen codierende Nukleotidsequenzen New coding for the eno gene nucleotide sequences |
| 04/12/2001 | CA2386419A1 Method for preparing steroids modified by yeast fermentation |
| 04/12/2001 | CA2386185A1 Fibrinolytically active polypeptide |
| 04/12/2001 | CA2386169A1 Improved fermentation process |
| 04/12/2001 | CA2385823A1 Production of recombinant aav using adenovirus comprising aav rep/cap genes |
| 04/12/2001 | CA2385696A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | CA2382859A1 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 04/12/2001 | CA2382830A1 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same |
| 04/11/2001 | EP1091004A2 Simultaneous detection, identification and differentiation of Eubacterial taxa using a hybridization assay |
| 04/11/2001 | EP1091000A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 04/11/2001 | EP1090999A2 Plant with modified flowers |
| 04/11/2001 | EP1090998A1 Nucleotide sequences coding for the eno gene |
| 04/11/2001 | EP1090995A2 Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof |
| 04/11/2001 | EP1090993A1 Nucleotide sequences coding for the lrp gene |
| 04/11/2001 | EP1090990A1 Human g-protein-coupled receptor |
| 04/11/2001 | EP1090988A1 Methods for the production of recombinant citrate lyase holo-enzyme |
| 04/11/2001 | EP1090136A1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 04/11/2001 | EP1090126A1 Microbial preparation of substances from aromatic metabolism/iii |
| 04/11/2001 | EP1090038A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 04/11/2001 | EP1089629A1 Novel biocontrol agents |
| 04/11/2001 | EP0733108B1 Mutants of bone morphogenetic proteins |
| 04/11/2001 | EP0710285B1 Analogues of an anti-thrombin polypeptide and process for their preparation |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291239A Fermentative preparation process for cytostatics and crystal form thereof |
| 04/11/2001 | CN1291238A Process for obtaining of HMG-CO A reductase inhibitors of high purify |